A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Alterome Therapeutics, Inc.
Olivia Newton-John Cancer Research Institute
City of Hope Medical Center
Mayo Clinic
DL Analytics
Corcept Therapeutics
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Arsenal Biosciences, Inc.
Marengo Therapeutics, Inc.
University of Utah